WHEN SAFETY MATTERS

Cytotoxic drugs, like chemotherapies, present hazards to patients and providers. The all-in-one AFS avoids advanced prep by pharmacists and enables healthcare providers to safely deliver these drugs at home or in the clinic.

AFS for oncology drugs

WHEN SPEED MATTERS

Seconds count when emergency medications need to be delivered. The AFS saves time and maintains safety when delivering life-saving medications.

afs for Emergency Medications

WHEN VOLATILITY MATTERS

Many dermatological drugs are volatile, meaning they rapidly evaporate at room temperature. The AFS packages drug in a hermetically-sealed ampoule, making it the perfect fit for volatile drugs.

AFS for Dermatology

WHEN STABILITY MATTERS

Drug-device interactions prevent many therapeutics from reaching prefilled syringe configurations. The AFS provides an optimal platform when drug stability and usability are required.

AFS for Optimizing Stability

stability + usability

Drug-device interactions limit usability options for many pharmaceuticals and biologics. The Ampulis AFS solves this problem by providing a hermetically-sealed primary drug container within a user-optimized syringe format.

Learn About AFS

ABOUT AMPULIS

The Ampulis team has a long track record of developing and commercializing innovative and high impact drug delivery devices.

ABOUT AMPULIS

Ampulis IN THE News

Pharma Ed Prefilled Syringe Conference (2024)

Events

Ampulis attended the PharmaEd Prefilled Syringe Conference in La Jolla, CA. Ampulis founder and CEO, Eric Sugalski, presented on the Ampoule Filled Syringe (AFS) - a novel drug delivery platform that optimizes usability and drug stability. Sugalski showcased the...

Partnership Opportunities in Drug Delivery (2024)

Events

Ampulis attended the Partnership Opportunities in Drug Delivery (PODD) Conference this year in Boston. Additionally, Ampulis founder and CEO, Eric Sugalski, presented on the Ampoule-Filled Syringe (AFS) platform as a unique solution to optimize drug stability and...

LEARN MORE

The best way for us to tell you more about Ampulis and the AFS platform is through our email series. If you are interested, please subscribe through the form below. Thanks!